International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 10, 2010, Pages 4446-4450

  Lortholary, Olivier ^a,b   Obenga, Gaelle ^a   Biswas, Pinaki ^c   Caillot, Denis ^d   Chachaty, Elisabeth ^e   Bienvenu, Anne Lise ^f   Cornet, Muriel ^g   Greene, John ^h   Herbrecht, Raoul ⁱ   Lacroix, Claire ^j   Grenouillet, Frédéric ^k   Raad, Issam ^l   Sitbon, Karine ^a   Troke, Peter ^m   Berger, Pierre ⁿ   Bonnin, Alain ^d   Bougnoux, Marie Elisabeth ^o   Brethon, Benoit ^j   Breton, Anne ^p   Cannas, Giovanna ^q   Dinh, Aurelien ^r   Kauffmann Lacroix, Catherine ^s   Legrand, Faezeh ^k   Petit, Arnaud ^t   Poirot, Jean Louis ^u   Pons, Denis ^v   Raffoux, Emmanuel ^j   Ranque, Stéphane ^w   Ribaux, Patricia ^j   Vekhoff, Anne ^g   Wyplosz, Benjamin ^x   more..

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PFIZER INC   (United States)

^d HÔPITAL DU BOCAGE   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f HOSPICES CIVILS DE LYON   (France)

^g HÔTEL DIEU   (France)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁱ HÔPITAL DE HAUTEPIERRE   (France)

^j SAINT LOUIS HOSPITAL   (France)

^k UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^m Institut Paoli Calmettes ^*  (United Kingdom)

ⁿ INSTITUT PAOLI CALMETTES   (France)

^o HÔPITAL NECKER ENFANTS MALADES   (France)

^p HÔPITAL DES ENFANTS   (France)

^q EDOUARD HERRIOT HOSPITAL   (France)

^r RAYMOND POINCARÉ HOSPITAL   (France)

^s POITIERS UNIVERSITY HOSPITAL   (France)

^t ARMAND TROUSSEAU HOSPITAL   (France)

^u HÔPITAL SAINT ANTOINE   (France)

^v UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^w TIMONE HOSPITAL   (France)

^x HÔPITAL PAUL BROUSSE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BRAIN INFECTION; CHILD; COMBINATION CHEMOTHERAPY; FEMALE; FUSARIOSIS; FUSARIUM MONILIFORME; FUSARIUM OXYSPORUM; FUSARIUM PROLIFERATUM; FUSARIUM SOLANI; FUSARIUM SUBGLUTINANS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINUSITIS; SURVIVAL TIME; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 77957334912     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00286-10     Document Type: Article

References (27)

1. Azor, M., J. Cano, J. Gene, and J. Guarro. 2009. High genetic diversity and poor in vitro response to antifungals of clinical strains of Fusarium oxysporum. J. Antimicrob. Chemother. 63:1152-1155.
2. Azor, M., J. Gene, J. Cano, and J. Guarro. 2007. Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob. Agents Chemother. 51:1500-1503.
3. Campo, M., R. E. Lewis, and D. P. Kontoyiannis. 2010. Invasive fusariosis in patients with hematologic malignancies at a cancer center. J. Infect. 60:331-337.
4. De Pauw, B. E., T. J. Walsh, J. P. Donnelly, D. A. Stevens, J. E. Edwards, T. Calandra, P. G. Pappas, J. Maertens, O. Lortholary, C. A. Kauffman, D. W. Denning, T. F. Patterson, G. Maschmeyer, J. Bille, W. E. Dismukes, R. Herbrecht, W. W. Hope, C. C. Kibbler, B. J. Kullberg, K. A. Marr, P. Muñoz, F. C. Odds, J. R. Perfect, A. Restrepo, M. Ruhnke, B. H. Segal, J. D. Sobel, T. C. Sorrell, C. Viscoli, J. R. Wingard, T. Zaoutis, and J. E. Bennett. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
5. Dignani, M. C., and E. Anaissie. 2004. Human fusariosis. Clin. Microbiol. Infect. 10(Suppl. 1):67-75.
6. Espinel-Ingroff, A., E. Johnson, H. Hockey, and P. Troke. 2008. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole phase III clinical studies. J. Antimicrob. Chemother. 61:616-620.
7. Iqbal, N. J., A. Boey, B. J. Park, and M. E. Brandt. 2008. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn. Microbiol. Infect. Dis. 62:348-350.
8. Iyer, S. A., S. S. Tuli, and R. C. Wagoner. 2006. Fungal keratitis: emerging trends and treatment outcomes. Eye Contact Lens 32:267-271.
9. Latenser, B. A. 2003. Fusarium infections in burn patients: a case report and review of the literature. J. Burn Care Rehab. 24:285-288. (Pubitemid 37128442)
10. Morgavi, D., and R. T. Riley. 2007. Fusarium and their toxins: mycology, occurrence, toxicity, control and economic impact. Anim. Feed Sci. Technol. 137:199-200.
11. Neofytos, D., D. Horn, E. Anaissie, W. Steinbach, A. Olyaei, J. Fishman, M. Pfaller, C. Chang, K. Webster, and K. Marr. 2009. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin. Infect. Dis. 48:265-273.
12. Nucci, M., and E. Anaissie. 2007. Fusarium infections in immunocompromised patients. Clin. Microbiol. Rev. 20:695-704.
13. Nucci, M., E. J. Anaissie, F. Queiroz-Telles, C. A. Martins, P. Trabasso, C. Solza, C. Mangini, B. P. Simoes, A. L. Colombo, J. Vaz, C. E. Levy, S. Costa, V. A. Moreira, J. S. Oliveira, N. Paraguay, G. Duboc, J. C. Voltarelli, A. Maiolino, R. Pasquini, and C. A. Souza. 2003. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 98:315-319.
14. Nucci, M., K. A. Marr, F. Queiroz-Telles, C. A. Martins, P. Trabasso, S. Costa, J. C. Voltarelli, A. L. Colombo, A. Imhof, R. Pasquini, A. Maiolino, C. A. Souza, and E. Anaissie. 2004. Fusarium infection in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 38:1237-1242.
15. Pagano, L., M. Caira, A. Candoni, M. Offidani, L. Fianchi, B. Martino, D. Pastore, M. Picardi, A. Bonini, A. Chierichini, R. Fanci, C. Caramatti, R. Invernizzi, D. Mattei, M. E. Mitra, L. Melillo, F. Aversa, M. T. Van Lint, P. Falcucci, C. G. Valentini, C. Girmenia, and A. Nosari. 2006. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91:1068-1075. (Pubitemid 44208634)
16. Perfect, J. R. 2005. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin. Infect. Dis. 40(Suppl. 6):S401-S408.
17. Perfect, J. R., K. A. Marr, T. J. Walsh, R. N. Greenberg, B. DuPont, J. de la Torre-Cisneros, G. Just-Nubling, H. T. Schlamm, I. Lutsar, A. Espinel-Ingroff, and E. Johnson. 2003. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin. Infect. Dis. 36:1122-1131.
18. Pfaller, M. A., S. A. Messer, R. J. Hollis, and R. N. Jones. 2002. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob. Agents Chemother. 46:1032-1037.
19. Pitt, J. 2000. Toxigenic fungi: which are important? Med. Mycol. 38:17-22. (Pubitemid 32094051)
20. Raad, I. I., R. Y. Hachem, R. Herbrecht, J. R. Graybill, R. Hare, G. Corcoran, and D. P. Kontoyiannis. 2006. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin. Infect. Dis. 42:1398-1403.
21. Raad, I., J. Tarrand, H. Hanna, M. Albitar, E. Janssen, M. Boktour, G. Bodey, M. Mardani, R. Hachem, D. Kontoyiannis, E. Whimbey, and K. Rolston. 2002. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect. Control Hosp. Epidemiol. 23:532-537.
22. Sampathkumar, P., and C. V. Paya. 2001. Fusarium infection after solidorgan transplantation. Clin. Infect. Dis. 32:1237-1240.
23. Segal, B. H., R. Herbrecht, D. A. Stevens, L. Ostrosky-Zeichner, J. Sobel, C. Viscoli, T. J. Walsh, J. Maertens, T. F. Patterson, J. R. Perfect, B. Dupont, J. R. Wingard, T. Calandra, C. A. Kauffman, J. R. Graybill, L. R. Baden, P. G. Pappas, J. E. Bennett, D. P. Kontoyiannis, C. Cordonnier, M. A. Viviani, J. Bille, N. G. Almyroudis, L. J. Wheat, W. Graninger, E. J. Bow, S. M. Holland, B. J. Kullberg, W. E. Dismukes, and B. E. De Pauw. 2008. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases. Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria. Clin. Infect. Dis. 47:674-683.
24. Stanzani, M., F. Tumietto, N. Vianelli, and M. Baccarani. 2007. Update on the treatment of disseminated fusariosis: focus on voriconazole. Ther. Clin. Risk Manag. 3:1165-1173.
25. Torres, H. A., I. I. Raad, and D. P. Kontoyiannis. 2003. Infections caused by Fusarium species. J. Chemother. 15:28-35.
26. Tortorano, A. M., A. Prigitano, G. Dho, E. Biraghi, D. A. Stevens, M. Ghannoum, N. Nolard, and M. A. Viviani. 2008. In vitro activity of amphotericin B against Aspergillus terreus isolates from different countries and regions. J. Chemother. 20:756-757.
27. Windels, C. 2000. Economic and social impacts of Fusarium head blight: changing farms and rural communities in the Northern Great Plains. Phytopathology 90:17-21. (Pubitemid 30028263)